Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Entropy Neurodynamics is a specialized neurotechnology company that develops advanced quantitative electroencephalography (qEEG) and brain mapping software. The company is primarily known for its contributions to the NeuroGuide platform, which provides clinicians and researchers with tools for brain network analysis and neurofeedback. By utilizing extensive normative databases, their technology allows for the identification of functional abnormalities in the brain associated with various neurological and psychiatric conditions. Entropy Neurodynamics focuses on bridging the gap between basic neuroscience research and clinical application through high-resolution EEG analysis. Their products are widely utilized in the assessment of traumatic brain injury, epilepsy, and learning disabilities. The company's innovations include real-time Z-score neurofeedback and 3D source localization techniques.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Entropy Neurodynamics.